study

Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 ReinforcingBest-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohns DiseaseTeva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 ReinforcingBest-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohns Disease

Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 ReinforcingBest-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohns Disease

Teva hosting investor call Monday, February 24 at 8:00 a.m. U.S. ET February 22, 2025 02:20 ET  | Source: Teva…

13 hours ago
Woxsen University Collaborate on AI Study to Predict Deceptive Movements in CricketWoxsen University Collaborate on AI Study to Predict Deceptive Movements in Cricket

Woxsen University Collaborate on AI Study to Predict Deceptive Movements in Cricket

HYDERABAD, India, Feb. 19, 2025 /PRNewswire/ -- Woxsen University's Artificial Intelligence Research Centre (AIRC) and Kuwait College of Science and…

2 days ago
Mars launches landmark global study program on pets’ contribution to human wellbeingMars launches landmark global study program on pets’ contribution to human wellbeing

Mars launches landmark global study program on pets’ contribution to human wellbeing

Mars announces intention to undertake world's largest international study program into the human-animal bond and the role of cats and…

3 days ago
NextGenInnov8 Announces Publication of Case Study on Young Innovator Aditya Pachpande, Aligned with India’s Push for STEM and Innovation EducationNextGenInnov8 Announces Publication of Case Study on Young Innovator Aditya Pachpande, Aligned with India’s Push for STEM and Innovation Education

NextGenInnov8 Announces Publication of Case Study on Young Innovator Aditya Pachpande, Aligned with India’s Push for STEM and Innovation Education

PUNE, India, Feb. 18, 2025 /PRNewswire/ -- NextGenInnov8, a forward-thinking organization fostering innovation among youth, is proud to announce the…

5 days ago
TAHO Pharmaceuticals Reports Positive Results from Pivotal Study of TAH3311, the First Oral Dissolving Film AnticoagulantTAHO Pharmaceuticals Reports Positive Results from Pivotal Study of TAH3311, the First Oral Dissolving Film Anticoagulant

TAHO Pharmaceuticals Reports Positive Results from Pivotal Study of TAH3311, the First Oral Dissolving Film Anticoagulant

TAIPEI, Feb. 17, 2025 /PRNewswire/ -- TAHO Pharmaceuticals announces positive preliminary results from the pivotal study of TAH3311, the world's…

5 days ago
Cisco Study: CEOs Embrace AI, But Knowledge Gaps Threaten Strategic Decisions and GrowthCisco Study: CEOs Embrace AI, But Knowledge Gaps Threaten Strategic Decisions and Growth

Cisco Study: CEOs Embrace AI, But Knowledge Gaps Threaten Strategic Decisions and Growth

97% of CEOs plan AI integration, but only 1.7% feel fully prepared. New research highlights what's getting in the way…

2 weeks ago
4DMT Presents Positive 52-Week Results from Phase 2b Cohort of PRISM Wet AMD Study and Long-term Durability Data Supporting 4D-150 4FRONT Global Registration Program4DMT Presents Positive 52-Week Results from Phase 2b Cohort of PRISM Wet AMD Study and Long-term Durability Data Supporting 4D-150 4FRONT Global Registration Program

4DMT Presents Positive 52-Week Results from Phase 2b Cohort of PRISM Wet AMD Study and Long-term Durability Data Supporting 4D-150 4FRONT Global Registration Program

February 08, 2025 14:30 ET  | Source: 4D Molecular Therapeutics, Inc. 3E10 vg/eye achieved an 83% reduction in injection burden…

2 weeks ago
IBM Study: Gen AI Will Elevate Financial Performance of Banks in 2025IBM Study: Gen AI Will Elevate Financial Performance of Banks in 2025

IBM Study: Gen AI Will Elevate Financial Performance of Banks in 2025

Initiatives are maturing from pilots and proofs of concept to targeted, enterprise-wide strategies ARMONK, N.Y., Feb. 5, 2025 /PRNewswire/ --…

2 weeks ago
Axtria Harnesses GenAI to Slash Timelines and Boost Accuracy in Clinical Study Reporting with Axtria Rapid CSRAxtria Harnesses GenAI to Slash Timelines and Boost Accuracy in Clinical Study Reporting with Axtria Rapid CSR

Axtria Harnesses GenAI to Slash Timelines and Boost Accuracy in Clinical Study Reporting with Axtria Rapid CSR

GenAI-powered solution delivers clinical study reports in minutes with 30%–50% faster turnarounds, 90% ICH-E3-aligned accuracy, and substantial cost savings. BERKELEY…

3 weeks ago
Spectral AI Completes Pediatric Enrollment in Emergency Departments for U.S. Burn Pivotal StudySpectral AI Completes Pediatric Enrollment in Emergency Departments for U.S. Burn Pivotal Study

Spectral AI Completes Pediatric Enrollment in Emergency Departments for U.S. Burn Pivotal Study

DALLAS, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven…

4 weeks ago